NCT06341101View on ClinicalTrials.gov

Timely Recovery After Subclinical Heart Failure

PHASE4RecruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

March 26, 2024

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2026

Conditions
Heart FailureDiastolic Dysfunction
Interventions
DRUG

Perindopril

In case of side effects Perindopril will be replaced by Valsartan

Trial Locations (1)

6202AZ

RECRUITING

AZMaastricht, Maastricht

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Academisch Ziekenhuis Maastricht

OTHER